CYTOF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Altamira Therapeutics (CYTOF) Ownership - Who owns Altamira Therapeutics?

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

N/A

Phone

N/A

Employees

N/A

Web

N/A

Details

Group

Domestic Stock Funds

Fundamentals

CYTOF

Capitalization

377K

P/E Ratio

0.05

Risk (Beta)

2.58

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

0.06

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

1.21K

Shares Outstanding - Current

3.78M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

-9.593

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company which engages in the development of novel products that address unmet medical needs in neurotology and central nervous system disorders.

Industry Biotechnology